Interline agreement to connect America's largest domestic carrier and Taiwan-based China Airlines through shared gateways in California, creating first trans-Pacific airline partnership for Southwest Airlines Southwest Airlines Co. (NYSE: LUV) and China Airlines Group, a Taiwan-based carrier, are in discussions to create an interline partnership in early 2026, with published connections expected to go on […]

AZZ Inc. (NYSE: AZZ),the leading independent provider of hot-dip galvanizing and coil coating solutions in North America, today announced thatDavid Nark, Chief Marketing, Communications, and Investor Relations Officer will participate in the Wolfe Research 2nd Annual Materials of the Future Conference 2025. https://mma.prnewswire.com/media/1959193/AZZ_3D__Logo.jpg The conference will be held on June 16-18, 2025, at the Wolfe

(TSX-V:FAN),(OTC US:FANCF),(Other OTC:FANCF),(Frankfurt:P21), VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) — First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) (“First Atlantic” or the “Company”) is pleased to announce its participation at the Benchmark Mineral Intelligence GIGA USA 2025 conference, taking place June 3-4, 2025, in Washington, DC. The Company will participate in

(NasdaqGM:VERA), Atacicept ORIGIN Phase 3 trial met the primary endpoint of reduction in proteinuria (UPCR) at week 36; participants receiving atacicept achieved a 46% reduction from baseline and 42% reduction compared to placebo at week 36 (p<0.0001) Other prespecified endpoints achieved similar or better results compared to the ORIGIN Phase 2b clinical trial — per

(NASDAQ:LQDA), YUTREPIA now available to be prescribed to patients via specialty pharmacies FDA approved YUTREPIA on May 23, 2025 Court denies United Therapeutics' request for preliminary injunction and a temporary restraining order, clearing the path for full commercial launch MORRISVILLE, N.C., June 02, 2025 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing

(NYSE:PDM), Atlanta, June 02, 2025 (GLOBE NEWSWIRE) — Piedmont Office Realty Trust, Inc. (“Piedmont” or “the Company”) (NYSE:PDM), an owner of Class A office properties located primarily in the Sunbelt, announced today, that the Company is participating in this week's Nareit REITWeek Investor Conference in New York City. The Company has completed over 500,000 square

(NYSE MKT:GPUS), LAS VEGAS, June 02, 2025 (GLOBE NEWSWIRE) — Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (“Hyperscale Data” or the “Company“), today announced the sale of its minority equity interest in a privately held pharmaceutical company for gross proceeds of $4.65 million in cash. Hyperscale Data purchased the equity position for

First Atlantic Nickel to Attend Benchmark Mineral Intelligence's GIGA USA 2025 Conference, Highlighting Atlantic Nickel Project's Smelter-Free Processing for North America's Critical Minerals Supply Chain GlobeNewswire June 02, 2025 VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) — First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) (“First Atlantic” or the “Company”) is pleased

Vera Therapeutics Announces Atacicept Achieved 46% Proteinuria Reduction in ORIGIN Phase 3 Trial in Adults with IgA Nephropathy GlobeNewswire June 02, 2025 Atacicept ORIGIN Phase 3 trial met the primary endpoint of reduction in proteinuria (UPCR) at week 36; participants receiving atacicept achieved a 46% reduction from baseline and 42% reduction compared to placebo at

Liquidia Schedules First Commercial Shipment of YUTREPIA(TM) (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD GlobeNewswire June 02, 2025 YUTREPIA now available to be prescribed to patients via specialty pharmacies FDA approved YUTREPIA on May 23, 2025 Court denies United Therapeutics' request for preliminary injunction and a temporary restraining order, clearing the path for